Systemic vascular resistance during brief withdrawal of angiotensin converting enzyme inhibition in heart failure

Author： Gabrielsen A.   Bie P.   Christensen N.   Frandsen E.   Galatius S.   Pump B.   Sørensen V. B.   Kastrup J.   Norsk P.  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.62, Iss.4, 2002-06, pp. : 245-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Changes in Vascular Distensibility during Angiotensin-Converting Enzyme Inhibition Involve Bradykinin Type 2 Receptors

By  

Journal of Vascular Research, Vol. 41, Iss. 1, 2004-02 ,pp. : 18-27

Karger

Access to resources Recommend Favorite

Discontinuation/Dose Reduction of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers during Acute Decompensated Heart Failure in African-American Patients with Reduced Left-Ventricular Ejection Fraction

By  

Cardiology, Vol. 137, Iss. 2, 2017-04 ,pp. : 121-125

Karger

Access to resources Recommend Favorite

Age and the Renal Blood Supply: Renal Vascular Responses to Angiotensin Converting Enzyme Inhibition in Healthy Humans

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 42, Iss. 8, 1994-08 ,pp. : 805-808

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sarcopenia – A Potential Target for Angiotensin-Converting Enzyme Inhibition?

By  

Gerontology, Vol. 52, Iss. 4, 2006-07 ,pp. : 237-242

Karger

Access to resources Recommend Favorite

Angiotensin‐Converting Enzyme Inhibitor Use in Older Patients with Heart Failure and Renal Dysfunction

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 47, Iss. 3, 1999-03 ,pp. : 302-308

John Wiley & Sons Inc

Access to resources Recommend Favorite